Pharmaceuticals

Non-Viral Gene Delivery Technologies Market Revenue Forecast to Reach $9.26 Billion by 2030 at 15.1% CAGR

March 23, 2026March 24, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Expected Market Size Of The Non-Viral Gene Delivery Technologies Market From 2026 To 2030?

The non-viral gene delivery technologies market has experienced rapid expansion in recent years. It is projected to increase from $4.57 billion in 2025 to $5.28 billion in 2026, achieving a compound annual growth rate (CAGR) of 15.5%. This historical growth can be attributed to factors such as the dependence on viral delivery methods, the restricted supply of non-viral transfection reagents, increasing engagement in gene therapy research, the rising utilization of plasmid DNA and mRNA delivery kits, and the implementation of electroporation and other physical delivery techniques.

The non-viral gene delivery technologies market is projected to experience substantial expansion in the coming years. By 2030, its size is anticipated to reach $9.26 billion, demonstrating a compound annual growth rate (CAGR) of 15.1%. This projected growth during the forecast period is driven by several factors, including the advancement of sophisticated lipid and polymer nanoparticles, the wider availability of pre-formulated nanoparticle technologies, increasing capital directed towards gene editing and RNAi therapeutics, the rising need for customized gene therapy options, and the incorporation of high-throughput and automated delivery systems. Key developments expected during this period involve the increasing use of lipid-based and polymer-based non-viral delivery mechanisms, a surge in CRISPR and Cas9 gene editing applications, heightened demand for RNAi and DNA vaccine delivery platforms, an increase in ex-vivo and in-vivo gene therapy investigations, and the creation of cell-specific and targeted gene delivery reagents.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27367&type=smp

What Major Drivers Are Influencing Demand In The Non-Viral Gene Delivery Technologies Market?

The growing need for tailored medical treatments is anticipated to drive expansion within the non-viral gene delivery technologies market in the future. Personalized medicine refers to a healthcare strategy where prevention, diagnosis, and treatment are adapted to an individual’s distinct genetic profile, lifestyle choices, and environmental factors. This rising demand for personalized healthcare stems from progress in genomic sequencing techniques, enabling more precise diagnoses, specific therapeutic interventions, and enhanced patient-specific treatment results. The heightened emphasis on personalized medicine is boosting the need for non-viral gene delivery technologies because these methods provide safer and more flexible ways to introduce therapeutic genes suited to a person’s genetic characteristics, bypassing the hazards linked with viral vectors. As an illustration, in February 2024, data from the Personalized Medicine Coalition, a US-based non-profit body, indicated that the Food and Drug Administration (FDA) sanctioned 16 new personalized treatments for individuals with rare conditions in 2023, an increase from 6 approvals in 2022. Consequently, the expanding requirement for personalized medicine is fueling the growth of the non-viral gene delivery technologies market.

Which Segments Are Included In The Analysis Of The Non-Viral Gene Delivery Technologies Market?

The non-viral gene delivery technologies market covered in this report is segmented –

1) By Product: Reagents And Kits, Delivery Devices, Pre-Formulated Nanoparticles

2) By Delivery: In-Vitro, In-Vivo, Ex-Vivo

3) By Technology: Electroporation, Lipid-Based Transfection, Polymer-Based Transfection, Physical Methods (Microinjection, Gene Gun), Nanoparticles

4) By Application: Gene Therapy, Deoxyribonucleic Acid (DNA) Vaccines, Ribonucleic Acid Interference (RNAi), Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Or Cas9 Gene Editing, Protein Expression

5) By End-Use: Biotechnology And Biopharmaceutical Companies, Research And Academic Institutes, Other End-Uses

Subsegments:

1) By Reagents And Kits: Transfection Reagents, Plasmid Deoxyribonucleic Acid (DNA) Kits, Messenger Ribonucleic Acid (RNA) Delivery Kits, Small Interfering Ribonucleic Acid (RNA) Delivery Kits, Clustered Regularly Interspaced Short Palindromic Repeats Associated Protein Reagents, Cell-Specific Delivery Reagents

2) By Delivery Devices: Electroporation Systems, Microinjection Systems, Gene Guns Or Biolistic Delivery Devices, Ultrasound-Mediated Delivery Devices, Hydrodynamic Gene Delivery Systems

3) By Pre-Formulated Nanoparticles: Lipid-Based Nanoparticles, Polymer-Based Nanoparticles, Gold-Based Nanoparticles, Dendrimer-Based Nanoparticles, Carbon Nanotube-Based Nanoparticles, Inorganic Compound-Based Nanoparticles

Which Trends Are Impacting The Growth Of The Non-Viral Gene Delivery Technologies Market?

Companies operating in the non-viral gene delivery market are concentrating on developing sophisticated solutions, such as non-viral genetic medicine platforms, to elevate the safety and effectiveness of gene therapies. A non-viral genetic medicine platform is a technology designed to introduce therapeutic genes or nucleic acids into cells without the use of viruses, thereby mitigating immune responses and safety concerns, and facilitating precise and regulated gene therapy delivery for a multitude of diseases. For example, in October 2023, Generation Bio Co., a US-based biotechnology company specializing in genetic medicines, unveiled immune-quiet DNA (iqDNA). This innovative DNA is an improved variant of their closed-ended DNA (ceDNA) that effectively avoids detection by the innate immune system, exhibiting cytokine levels and tolerability comparable to chemically modified mRNA in studies involving mice and non-human primates when delivered through their lipid nanoparticle (LNP) system. Given iqDNA’s superior tolerability, Generation Bio is advancing it as the primary DNA cargo for all its programs, including its flagship hemophilia A initiative.

Which Key Industry Participants Are Active In The Non-Viral Gene Delivery Technologies Market?

Major companies operating in the non-viral gene delivery technologies market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Evonik Industries AG, Moderna Inc., Lonza Group AG, Bio-Rad Laboratories Inc., Takara Bio Inc., GenScript Biotech Corporation, ReCode Therapeutics Inc., Altogen Biosystems Inc., Generation Bio, Indee Labs Inc.

Read the full non-viral gene delivery technologies market report here:

https://www.thebusinessresearchcompany.com/report/non-viral-gene-delivery-technologies-global-market-report

Which Region Shows The Strongest Potential For Future Growth In The Non-Viral Gene Delivery Technologies Market?

North America was the largest region in the non-viral gene delivery technologies market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the non-viral gene delivery technologies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Non-Viral Gene Delivery Technologies Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=27367&type=smp

Browse Through More Reports Similar to the Global Non-Viral Gene Delivery Technologies Market 2026, By The Business Research Company

Low Density Polyethylene Market Report 2026

https://www.thebusinessresearchcompany.com/report/low-density-polyethylene-global-market-report

Polyethylene Pipes Market Report 2026

https://www.thebusinessresearchcompany.com/report/polyethylene-pipes-global-market-report

High Density Polyethylene Market Report 2026

https://www.thebusinessresearchcompany.com/report/high-density-polyethylene-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795